SoftBank Group
9984
Remixpoint
3825
FUJI Media Holdings
4676
4
SoftBank
9434
5
Fujikura
5803
JP Stock MarketDetailed Quotes
130A Veritas In Silico
- 801
- +1+0.13%
20min DelayNot Open Jan 22 15:30 JST
5.20BMarket Cap133.28P/E (Static)
811High787Low10.00KVolume800Open800Pre Close7.98MTurnover347552wk High0.61%Turnover Ratio6.49MShares63752wk Low6.01EPS TTM1.31BFloat Cap3475Historical High133.28P/E (Static)1.63MShs Float637Historical Low6.01EPS LYR3.00%Amplitude--Dividend TTM2.21P/B100Lot Size--Div YieldTTM
About Veritas In Silico Company
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
Company Profile
Symbol130A
Company NameVeritas In Silico
Founded2016-11-17
MarketTSE Growth
Fiscal Year Ends12-31
Address1-11-1, Nishigotanda Shinagawa-ku
Zip Code141-0031
Phone03-6421-7537
Websitewww.veritasinsilico.com
Company Executives
- Name
- Position
- Salary
- Shingo Nakamura
- Representative Director and President
- --
- Takashi Uemura
- Director and Head of Business Headquarters
- --
- Hiroyuki Matsuoka
- Director and Head of Management Headquarters
- --
- Kinichiro Konami
- Non-Executive Independent Director
- --